Related references
Note: Only part of the references are listed.Functional impairment of CD19+CD24hiCD38hi B cells in neuromyelitis optica spectrum disorder is restored by B cell depletion therapy
Yeseul Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
The B cell immunobiology that underlies CNS autoantibody-mediated diseases
Bo Sun et al.
NATURE REVIEWS NEUROLOGY (2020)
Less frequent rituximab retreatment maintains remission of neuromyelitis optica spectrum disorder, following long-term rituximab treatment
Su-Hyun Kim et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children
Nicolaas G. van der Maas et al.
FRONTIERS IN IMMUNOLOGY (2019)
Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
Robert Wilson et al.
BRAIN (2018)
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML
L. Diamanti et al.
BONE MARROW TRANSPLANTATION (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
B lymphocytes in neuromyelitis optica
Jeffrey L. Bennett et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
Michel Varrin-Doyer et al.
ANNALS OF NEUROLOGY (2012)
Myasthenia gravis and neuromyelitis optica spectrum disorder A multicenter study of 16 patients
M. I. Leite et al.
NEUROLOGY (2012)
Share Paper
